Palantir falls 12% as analysts raise international growth concerns

Palantir falls 12% as analysts raise international growth concerns


Palantir co-founder and CEO Alex Karp speaks during the Hill & Valley Forum at the US Capitol Visitor Center Auditorium in Washington, DC, on April 30, 2025.

Brendan Smialowski | Afp | Getty Images

Palantir shares dropped more than 10% Tuesday even after the data analytics and artificial intelligence software company showed ongoing revenue growth acceleration.

“Some investors may be disappointed with the modest full- year revenue guidance raise, the sequential margin decline, and the international commercial revenue year-over-year decline,” wrote William Blair analyst Louie DiPalma, adding that the company’s high software multiple makes it “vulnerable” to compression as revenue growth slows.

Despite the post-earnings move, Palantir topped revenue expectations and lifted its revenue guidance for the year. The Denver-based company posted adjusted earnings of 13 cents per share on $884 million in revenues. Analysts polled by LSEG had expected adjusted EPS of 13 cents and revenues of $863 million.

Palantir’s revenues rose 39% from $634.3 million in the year-ago quarter. Net income grew to about $214 million, or 8 cents per share, from roughly $105.5 million, or 4 cents per share, a year ago. The company also hiked its full-year revenue outlook to between $3.89 billion and $3.90 billion

CEO Alex Karp said that “Palantir is on fire” and he’s “very optimistic” about the current setup during the earnings call after the bell Monday.

“The reality of what’s going on is that this is an unvarnished cacophony — the combination of 20 years of investment and a massive cultural shift in the U.S. which is generating numbers,” he said.

Palantir has outperformed the market this year, building on a successful 2024 run in which the stock was the best performer in the S&P 500. Many on Wall Street say the surge in shares has contributed to an elevated multiple for the company, making the bar higher and higher to clear. To be sure, the stock has undergone immense volatility amid the latest batch of market volatility spurred by President Donald Trump’s tariff plans.

“While 2025 numbers move higher on guidance ahead of consensus, we question conservatism and if estimate revisions are priced in from here,” said RBC Capital Markets analyst Rishi Jaluria.

Despite the company’s strong execution and fundamentals, Mizuho’s Gregg Moskowitz also said it’s “very difficult to justify” its high multiple. Raymond James analyst Brian Gesuale said that Palantir needs to consolidate some of its gains to “grow into its rich valuation.”

Wall Street also highlighted a deceleration in international commercial revenues among the reasons for the potential decline in shares. The segment fell 5% year over year after rising 3% in the previous quarter due to headwinds in Europe.

Management said on an earnings call that the region is “going through a very structural change and doesn’t quite get AI.”

Stock Chart IconStock chart icon

hide content

Palantir ytd share chart

Palantir meets earnings expectations, beats on revenue



Source

Synopsys pulls full-year guidance, citing new China export restrictions
Technology

Synopsys pulls full-year guidance, citing new China export restrictions

Sassine Ghazi, CEO of semiconductor design software firm Synopsys, explains the company’s plans to have artificial intelligence take over parts of designing computer chips at the company’s annual user conference in Santa Clara, California, on March 19, 2025. Stephen Nellis | Reuters Synopsys pulled its guidance for the full fiscal year on Thursday, citing a […]

Read More
Meta and Anduril defense startup partner on VR, AR project intended for U.S. Army
Technology

Meta and Anduril defense startup partner on VR, AR project intended for U.S. Army

Palmer Luckey, Founder @ Oculus VR Andutil Industries, during day two of Collision 2019 at Enercare Center in Toronto, Canada. Stephen McCarthy | Sportsfile | Getty Images Meta and Anduril, the defense-tech startup founded by Palmer Luckey, announced Thursday that they’ve formed a partnership to create virtual and augmented reality devices intended for use by […]

Read More
Omada Health aims to go public with market cap of up to .1 billion
Technology

Omada Health aims to go public with market cap of up to $1.1 billion

Omada Health smart devices in use. Courtesy: Omada Health Omada Health plans to raise up to $158 million in its up coming IPO, attaining a market cap of about $1.1 billion at the top end of its expected range, according to a filing on Thursday. The virtual chronic care company filed its prospectus earlier this […]

Read More